Interferon signaling in Peromyscus leucopus confers a potent and specific restriction to vector-borne flaviviruses

Adaeze O Izuogu1, Kristin L McNally2, Stephen E Harris3

  • 1Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States of America.

Plos One
|June 27, 2017
PubMed

Insights

White-footed mice resist tick-borne flaviviruses due to a potent type I interferon response that blocks viral RNA replication. This natural resistance mechanism in Peromyscus leucopus offers insights for developing new antiviral therapies.

Area of Science:

  • Virology
  • Immunology
  • Host-Pathogen Interactions

Background:

  • Tick-borne flaviviruses (TBFVs) cause severe human diseases like encephalitis and hemorrhagic fevers.
  • Natural rodent hosts exhibit resistance to TBFV-induced disease, but the underlying mechanisms are unknown.
  • Co-evolution between TBFVs and hosts likely shaped potent antiviral defense mechanisms.

Purpose of the Study:

  • To investigate the cellular basis for resistance to TBFV infection in reservoir host cells.
  • To identify the specific stages of the viral life cycle blocked in resistant cells.
  • To determine the role of the type I interferon (IFN) pathway in mediating flavivirus resistance.

Main Methods:

  • Primary fibroblasts from white-footed mice (Peromyscus leucopus) and laboratory mice (Mus musculus) were infected with TBFVs.
  • Virus replication and specific life cycle stages (entry, RNA replication) were analyzed.
  • RNA interference was used to knock down key components of the type I IFN pathway (STAT1, IFNAR1).

Main Results:

  • P. leucopus cells showed a significant reduction (up to 10,000-fold) in TBFV titer compared to M. musculus cells.
  • A block in viral RNA replication, not virus entry, was identified in P. leucopus cells.
  • Knockdown of STAT1 or IFNAR1 in P. leucopus cells restored TBFV replication, implicating the type I IFN response.

Conclusions:

  • The type I interferon response in P. leucopus provides a strong, virus-specific barrier against flavivirus replication.
  • This resistance is not due to ineffective viral antagonism but rather a robust host antiviral state.
  • Understanding these IFN-stimulated genes could lead to novel antiviral therapeutic strategies.